Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT05790278
Other study ID # 1920306
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date August 1, 2022
Est. completion date August 31, 2024

Study information

Verified date February 2024
Source Allina Health System
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

At present, there is no empirical data that specifies the likely prevalence of purpose in life disruption among various clinical populations. Between one-third and one-half of cancer survivors report some degree of existential distress during or after their treatment, but these findings are not specific to the domain of purpose in life. To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 300
Est. completion date August 31, 2024
Est. primary completion date August 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18+ - Stage 1, 2, 3 cancer - Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer - Receiving oncology services or treatment through AHCI - Have completed primary cancer treatment within the past 12 months - Able to communicate in English; - Able to see and read (with or without assistive devices); - Has access to a device (computer, phone, tablet) and an email address; - Access to an internet connection. - Has a known email address (in EPIC) and/or home telephone number - Adults who sustained a traumatic brain injury within the past 12 months. - Attending the 2022 MN State Fair Exclusion Criteria: - Have declined consent for use of medical records in research during admission to AH facility

Study Design


Intervention

Other:
Survey
Completion of a Purpose in Life Survey

Locations

Country Name City State
United States Abbott Northwestern Hospital Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mary Radomski

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Purpose Status Question A single forced-choice self-report screener question that we developed in order to characterize existential distress related to purpose in life (PSQ: "Related to living with purpose in life, right now I am: moving backwards; stalled; figuring it out; moving forward on a path"). Through Study Completion, about 15 minutes
Secondary Work and Adjustment Scale A 5-item self-report questionnaire to characterize functioning related to work, social life, leisure, home management, and relationships. Through Study Completion, about 15 minutes
Secondary Meaning in Life Questionnaire A 10-item questionnaire designed to measure 2 dimensions of meaning in life: Presence of Meaning (how much respondents feel their lives have meaning) and Search for Meaning (how much respondents strive to find meaning and understanding in their lives). Through Study Completion, about 15 minutes
Secondary Life Engagement Test A 6-item self-report questionnaire that captures the extent to which a person engages in activities that are personally valued. Through Study Completion, about 15 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A